Rare diseases
Investigational molecules
Locations
Back to Bulgaria100 clinical trials in Burgas, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
BulgariaA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
BulgariaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
BulgariaLong-Term Safety Study of Plozasiran for Adults with High Triglycerides
BulgariaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
BulgariaStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
BulgariaStudy of Plozasiran for Adults with Severe Hypertriglyceridemia
BulgariaStudy on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer
BulgariaStudy to Evaluate Plozasiran for Adults with High Triglycerides
BulgariaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol in Patients Aged 40-80 with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
BulgariaStudy of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lung cancer and breast cancer treatments, including studies of novel therapies for metastatic conditions. Research encompasses both targeted and immunotherapy approaches.
Emphasis on developing treatments for patients with specific genetic markers and testing new combination therapies.
Comprehensive research into cardiovascular disease prevention and treatment, including innovative approaches to managing atherosclerosis and stroke prevention.
Multiple trials evaluating new compounds for lipid management and cardiovascular risk reduction.
Studies focused on chronic respiratory conditions including COPD and asthma, testing advanced inhalation therapies and novel treatment approaches.
Investigation of new therapeutic combinations and delivery systems for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
